Arkolith/Insider Trading/ADAP/Form 4

Allen Andrew R

DirectorAdaptimmune Therapeutics PLC (ADAP) · full profile →Form 4 · filed Jul 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 5, 2023Grant(A)57K—$057K
Jul 5, 2023Grant(A)152K—$0152K
Jul 5, 2023Grant(A)110K—$0110K
Jul 5, 2023Grant(A)110K—$0110K
Jul 5, 2023Grant(A)45K—$045K
Jul 5, 2023Grant(A)73K—$073K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-078197) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML